Allele Frequencies of HLA Class-I Loci in the Normal Iranian Population

Allele Frequencies of HLA Class-I Loci in the Normal Iranian Population

Show other versions (1)

"nIntroduction: Human Leukocyte Antigen (HLA) genes are the most polymorphic loci in the human genome. They predict the outcome of transplantation by detecting self from non-self antigens. The best use of HLA typing is to find a HLA-match donor for BMT candidate patients. Evidence suggests...

Full description

Bibliographic Details
Main Authors:	Andisheh Ghashghaie, Kamran Alimoghaddam, Mohammad Reza Ostadali, Hamid-o-allah Ghaffari, L Khansari, M Sadraee, E Mirrasekhian, Iranna Mohyedin, F Raoofi, Z Noori, H Yaghmaian, H Eshaghi, Ardeshir Ghavamzadeh
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2009-04-01
Series:	International Journal of Hematology-Oncology and Stem Cell Research
Subjects:	HLA, Cord Blood, GvHD, Frequency Transplantation, Donor.
Online Access:	http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/16091.pdf&manuscript_id=16091

Similar Items

Allele Frequencies of HLA Class-I Loci in the Normal Iranian Population
by: Andisheh Ghashghaie, et al.
Published: (2009-06-01)

Indirectly recognized HLA-C mismatches and their potential role in transplant outcome
by: Kirsten Anne Thus, et al.
Published: (2014-05-01)

The Relationship between STR-PCR Chimerism Analysis and Chronic GvHD following Hematopoietic Stem Cell Transplantation
by: Seyed Asadollah Mousavi, et al.
Published: (2016-12-01)

Alloreactivity of virus-specific T cellsPossible implication of graft-versus-host disease and graft-versus-leukemia effects
by: Shigeo eFuji, et al.
Published: (2013-10-01)

Innovative Clinical Perspectives for CIK Cells in Cancer Patients
by: Martino Introna, et al.
Published: (2018-01-01)

Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease
by: Hongnga T. Le, et al.
Published: (2020-02-01)

The role of chemokines in mediating graft versus host disease (GVHD): opportunities for novel therapeutics
by: Marina Gomes Miranda Castor, et al.
Published: (2012-02-01)

Decreased Soluble Human Leukocyte Antigen E Levels in Patients After Allogeneic Hematopoietic Stem Cell Transplantation Are Associated With Severe Acute and Extended Chronic Graft-versus-Host Disease and Inferior Overall Survival
by: Lambros Kordelas, et al.
Published: (2020-01-01)

Bone marrow GvHD after allogeneic hematopoietic stem cell transplantation
by: Martin eSzyska, et al.
Published: (2016-03-01)

18F-FDG-PET-MRI for the assessment of acute intestinal graft-versus-host-disease (GvHD)
by: Wolfgang Roll, et al.
Published: (2021-09-01)

Editorial: Pathogenesis and Therapy of Graft-versus-Host Disease
by: Brian C. Betts, et al.
Published: (2019-07-01)

Die Rolle von Zytokin- und Zytokinrezeptorgenvariationen für die Ausprägung von GvHD und GvL nach allogener Blutstammzelltransplantation bei Patienten mit hämatologischer Neoplasie
by: Wermuth, Marieke
Published: (2014)

Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor Immunity
by: Brian C. Betts, et al.
Published: (2018-12-01)

Clinical use of statins in hematopoietic stem cell transplantation: Old drugs and new horizons
by: Mehdi Mohammadi, et al.
Published: (2016-04-01)

T-Cell Replete Myeloablative Haploidentical Bone Marrow Transplantation Is an Effective Option for Pediatric and Young Adult Patients With High-Risk Hematologic Malignancies
by: Emmanuel Katsanis, et al.
Published: (2020-06-01)

Differential Elimination of Anti-Thymocyte Globulin of Fresenius and Genzyme Impacts T-Cell Reconstitution After Hematopoietic Stem Cell Transplantation
by: Lisa V. E. Oostenbrink, et al.
Published: (2019-03-01)

Challenges in Conducting Studies in Chronic Graft-versus-Host Disease
by: Iskra Pusic, et al.
Published: (2019-03-01)

Advantages and Applications of CAR-Expressing Natural Killer Cells
by: Wolfgang eGlienke, et al.
Published: (2015-02-01)

Meta-Analysis of Genome-Wide Association and Gene Expression Studies Implicates Donor T Cell Function and Cytokine Pathways in Acute GvHD
by: Kati Hyvärinen, et al.
Published: (2020-02-01)

Differential MicroRNA Expression Levels in Cutaneous Acute Graft-Versus-Host Disease
by: Sadaf Atarod, et al.
Published: (2018-07-01)

Survival and Functional Immune Reconstitution After Haploidentical Stem Cell Transplantation in Atm-Deficient Mice
by: Ruth Pia Duecker, et al.
Published: (2021-06-01)

Profiling Tissue and Biofluid miR-155-5p, miR-155*, and miR-146a-5p Expression in Graft vs. Host Disease
by: Rachel E. Crossland, et al.
Published: (2021-03-01)

IMPACT OF HLA-DPB1 INCOMPATIBILITY ON THE RESULTS OF ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION FROM HLA-A-B-C–DRB1-DQB1-COMPATIBLE UNRELATED DONOR
by: E. G. Khamaganova, et al.
Published: (2018-05-01)

Mechanisms of Glucocorticoids in the modulation of Graft-versus-Host Disease and the Graft-versus-Leukemia Reaction
by: Li, Hu
Published: (2020)

"Thalassemia: Incidence and predictive factors for chronic GVHD after HLA-identical sibling marrow transplantation "
by: "Ghavamzadeh A, et al.
Published: (2002-03-01)

"Thalassemia: Incidence and predictive factors for chronic GVHD after HLA-identical sibling marrow transplantation "
by: "Ghavamzadeh A, et al.
Published: (2002-05-01)

Maturation and Phenotypic Heterogeneity of Human CD4+ Regulatory T Cells From Birth to Adulthood and After Allogeneic Stem Cell Transplantation
by: Tiago R. Matos, et al.
Published: (2021-01-01)

Logistics of an advanced therapy medicinal product during COVID-19 pandemic in Italy: successful delivery of mesenchymal stromal cells in dry ice
by: Giuseppe Astori, et al.
Published: (2020-11-01)

Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD)
by: Matthew Mankarious, et al.
Published: (2020-01-01)

Distinctive expression of Bcl-2 factors in regulatory T cells determines a pharmacological target to induce immunological tolerance
by: Sarah Sharon Gabriel, et al.
Published: (2016-03-01)

Editorial: Non-coding RNAs and Graft versus Host Disease
by: Pavan Reddy, et al.
Published: (2018-11-01)

Various forms of tissue damage and danger signals following hematopoietic stem cell transplantation
by: Abdulraouf eRamadan, et al.
Published: (2015-01-01)

The Unique Immunomodulatory Properties of MSC-Derived Exosomes in Organ Transplantation
by: Qingyuan Zheng, et al.
Published: (2021-04-01)

Biomarkers for Early Complications of Endothelial Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Do They Have a Potential Clinical Role?
by: Giuseppe Lia, et al.
Published: (2021-05-01)

Association of HLA-G Low Expressor Genotype with Severe Acute Graft-versus-Host Disease after sibling Bone Marrow Transplantation
by: Wahid eBoukouaci, et al.
Published: (2011-12-01)

Immune Reconstitution-Based Score for Risk Stratification of Chronic Graft-Versus-Host Disease Patients
by: Fabio Serpenti, et al.
Published: (2021-07-01)

Extracellular Vesicles After Allogeneic Hematopoietic Cell Transplantation: Emerging Role in Post-Transplant Complications
by: Giuseppe Lia, et al.
Published: (2020-03-01)

Editorial: Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation
by: Dominik Schneidawind, et al.
Published: (2020-03-01)

Ruxolitinib in GvHD (RIG) study: a multicenter, randomized phase 2 trial to determine the response rate of Ruxolitinib and best available treatment (BAT) versus BAT in steroid-refractory acute graft-versus-host disease (aGvHD) (NCT02396628)
by: Nikolas von Bubnoff, et al.
Published: (2018-11-01)

Treatment of Severe Steroid-Refractory Acute-Graft-vs.-Host Disease With Mesenchymal Stem Cells–Single Center Experience
by: Maja Česen Mazič, et al.
Published: (2018-07-01)